stars 1 stars 2 stars 3

Synthetic Biologics, Inc. (NYSE MKT: SYN) is a late-stage clinical company developing therapeutics designed to preserve the microbiome to protect and restore the health of patients. The Company's lead candidates poised for Phase 3 development are: (1) SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C), and (2) SYN-004 (ribaxamase) which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) beta-lactam antibiotics for the prevention of C. difficile infection (CDI), antibiotic-associated diarrhea (AAD) and the emergence of antimicrobial-resistance (AMR). The Company is also developing preclinical stage monoclonal antibody therapies for the prevention and treatment of pertussis and novel discovery stage biotherapeutics for the treatment of phenylketonuria (PKU).

View Top Employees from Synthetic Biologics, Inc.
Ticker SYN
Revenue $5.4 million
Employees 17 (5 on RocketReach)
Founded 2001
Address 9605 Medical Center Dr Ste 270, Rockville, Maryland 20850, US
Phone (301) 417-4364
Fax (301) 417-4367
JavaScript, HTML, PHP +13 more (view full list)
Category Biotechnology, Pharmaceuticals, Microbiome, Healthcare, Science and Engineering, Prevention of C. dificile Infection, Health Care, Irritable Bowel Syndrome with Constipation (IBS-C), Therapeutics
Web Rank 10 Million
Keywords synthetic biologics, syntheticbiology inc, syn, key opinion leaders in gastroenterology, human heart dotted diagram
Competitors ALX Oncology, Applied Therapeutics Inc, Aptahem, Cerecor, Inc., Helix Biopharma Corp (HBPCF)
SIC 28, 873, 283, 87
NAICS 32541, 325, 325412, 3254, 541, 54, 32

Synthetic Biologics, Inc. Questions

The Synthetic Biologics, Inc. annual revenue was $5.4 million in 2023.

Charles L is the Vice President, Statistics, Programming and Data Manageme of Synthetic Biologics, Inc..

5 people are employed at Synthetic Biologics, Inc..

Synthetic Biologics, Inc. is based in Rockville, Maryland.

The NAICS codes for Synthetic Biologics, Inc. are [32541, 325, 325412, 3254, 541, 54, 32].

The SIC codes for Synthetic Biologics, Inc. are [28, 873, 283, 87].

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users